Injective (INJ) is currently trading at $3.45, reflecting a 2.22% increase over the past 24 hours, while maintaining a daily range of $3.34 to $3.50. The volume stands at approximately 64.57 million, representing 18.72% of the market cap, indicating a healthy trading activity relative to its market size.

Technical indicators reveal that the 8, 13, and 21-hour simple moving averages (SMA) are all showing slight upward trends, with the 55-hour SMA displaying a more substantial increase of 2.68%. The one-hour Relative Strength Index (RSI) is neutral at 46, while the 7-day RSI of 55 suggests a slight bullish momentum without reaching overbought conditions.

Over the last week, INJ has seen a price increase of approximately 2.84%, with a more pronounced rise of 14.03% over the past 14 days. This positive momentum, alongside a 30-day change of 12.61%, suggests a sustained upward trend in investor sentiment.

The current price remains significantly lower than the all-time high of $52.62 achieved on March 14, 2024, indicating substantial room for growth if bullish sentiment continues. However, given the recent price action and the current RSI levels, it appears that INJ is stabilizing around the $3.40-$3.50 range.

Given the solid performance indicators, moderate volume, and favorable moving averages, the outlook for Injective is cautiously optimistic. Therefore, the recommendation is a Buy, as potential upward movement exists if the price maintains above the $3.40 support level and volume continues to support this trend.